Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T18:31:31.881Z.
Calculation as of: 2026-10-06T18:31:31.881Z.
Quote observation: 2026-10-06T17:47:55.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8657ba12ac344a819f0899d7de2248978a084c0ba083431926caf2bd9808189d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
GigCapital8 Corp.
Market Cap
$261.45M
Free Cash Flow Yield
N/A
Market Cap
$261.39M
Free Cash Flow Yield
N/A
Market Cap
$261.27M
Free Cash Flow Yield
N/A
Market Cap
$261.73M
Free Cash Flow Yield
N/A
Market Cap
$264.38M
Free Cash Flow Yield
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD |
|---|---|---|
| GigCapital8 Corp. (GIW) | $261.45M | N/A |
| Mountain Lake Acquisition Corp. II Class A Ordinary Shares (MLAA)vs › | $261.39M | N/A |
| Cantor Equity Partners V, Inc. Class A Ordinary Shares (CEPV)vs › | $261.27M | N/A |
| Art Technology Acquisition Corp. (ARTC)vs › | $261.25M | N/A |
| AMR Resources Acquisition Corp Class A Ordinary Shares (AMAC)vs › | $261.73M | N/A |
| FACT II Acquisition Corp (FACT)vs › | $260.85M | N/A |
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)vs › | $264.38M | N/A |
| Soren Acquisition Corp. (SORN)vs › | $263.53M | N/A |
| Plum Acquisition Corp. IV (PLMK)vs › | $259.16M | N/A |
| Virginia National Bankshares Corporation (VABK)vs › | $258.98M | N/A |
FCF Yield
N/A
Earnings Yield
1.48%
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
